Open access
Sep 2026
Acemannan as a potential therapeutic agent for cognitive impairment via modulation of cholinergic, oxidative, and inflammatory pathways: in vivo and in silico evidence
Sami I. Alzarea, T. Alsahli, A. Alzarea et al.
· 3 Biotech · 0 citations